CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 75% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
15.830
1.68%
Market Trading Hours* (UTC) Opens on Monday at 07:00

Mon - Fri: 07:00 - 11:00 11:03 - 15:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.140
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.025295 %
Charges from full value of position ($-4.81)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.025295%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.003377 %
Charges from full value of position ($0.64)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003377%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.1
Currency GBP
Margin 5%
Stock exchange United Kingdom of Great Britain and Northern Ireland
Commission on trade 0%

Key Stats
Prev. Close 16.1
Open 16.035
1-Year Change 17.69%
Day's Range 15.785 - 16.08
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 21, 2024 15.830 -0.085 -0.53% 15.915 16.120 15.690
Jun 20, 2024 16.100 -0.035 -0.22% 16.135 16.200 16.015
Jun 19, 2024 16.155 0.105 0.65% 16.050 16.180 15.910
Jun 18, 2024 16.105 0.080 0.50% 16.025 16.165 15.990
Jun 17, 2024 15.955 -0.115 -0.72% 16.070 16.085 15.860
Jun 14, 2024 15.985 -0.110 -0.68% 16.095 16.130 15.975
Jun 13, 2024 16.070 0.015 0.09% 16.055 16.160 15.970
Jun 12, 2024 16.035 -0.090 -0.56% 16.125 16.185 15.930
Jun 11, 2024 15.890 -0.185 -1.15% 16.075 16.380 15.890
Jun 10, 2024 16.130 -0.015 -0.09% 16.145 16.250 16.060
Jun 7, 2024 16.235 -0.040 -0.25% 16.275 16.380 16.085
Jun 6, 2024 16.350 -0.110 -0.67% 16.460 16.560 16.255
Jun 5, 2024 16.380 0.105 0.65% 16.275 16.610 16.275
Jun 4, 2024 16.120 0.185 1.16% 15.935 16.235 15.850
Jun 3, 2024 15.990 0.150 0.95% 15.840 16.350 15.820
May 31, 2024 17.400 0.360 2.11% 17.040 17.640 17.040
May 30, 2024 17.230 -0.260 -1.49% 17.490 17.490 17.230
May 29, 2024 17.220 -0.065 -0.38% 17.285 17.430 17.220
May 28, 2024 17.310 -0.290 -1.65% 17.600 17.715 17.310
May 24, 2024 17.715 -0.050 -0.28% 17.765 17.905 17.635

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

GSK Company profile

GlaxoSmithKline PLC - GSK CFD

GlaxoSmithKline (GSK) is a global healthcare company focussed in pharmaceuticals, vaccine development and consumer healthcare products. 

The company began as an apothecary shop in London in 1715. Today, GlaxoSmithKline is headquartered in Brentford, England, with regional offices in the US and Singapore. GlaxoSmithKline’s primary listing is on the London Stock Exchange under the ticker symbol ‘GSK’. The GSK stock price in the form of  American depositary shares is listed on the New York Stock Exchange.   

GlaxoSmithKline’s pharmaceutical business covers a broad portfolio of medicines in respiratory, HIV, immuno-inflammation and oncology. The company has a leadership position in respiratory disease medicines. GlaxoSmithKline’s HIV business is managed through its unit ViiV Healthcare, with Pfizer and Shionogi as minority shareholders. 

In addition to respiratory and HIV treatments, the company has a portfolio of pharmaceutical products for the treatment of conditions such as lupus, urology and anti-infectives. 

Its Established Products Portfolio (EPP) includes mature medicines in the areas of anti-infectives, allergy, central nervous system, dermatology, respiratory and urology. These products are an important part of our Emerging Markets business.

GlaxoSmithKline is actively researching the World Health Organisation’s three priority diseases - HIV/AIDS, tuberculosis and malaria.

GlaxoSmithKline is also one of the world’s largest vaccine companies with a portfolio of more than 20 vaccines. The company has 12 vaccine manufacturing sites around the world. One of its four global R&D centres is dedicated to mRNA technology.

GlaxoSmithKline’s consumer healthcare business has portfolio of brands that include Sensodyne, Parodontax, Polident, Advil, Voltaire, Panadol, Striven, Theraflu and Centrum across oral health, pain relief, cold, flu and allergy, digestive health, and vitamins, mineral and supplements segments. GlaxoSmithKline is set to spin-off its consumer healthcare business into an independent company under the name ‘Haleon’.’

The company pays dividends on a quarterly basis, in July, October, January and April.
Follow the GlaxoSmithKline stock price live at Capital.com today.

Industry: Pharmaceuticals (NEC)

980 Great West Road
BRENTFORD
MIDDLESEX TW8 9GS
GB

News

Bank of England preview: no rate cut just yet despite CPI returning to 2%

The Bank of England (BoE) is widely expected to keep rates unchanged when it meets on Thursday. Analyst Daniela Harthorn looks at what this could mean

12:45, 18 June 2024

RBA Meeting Preview: No change to policy expected, markets look for fresh guidance

The Reserve Bank of Australia is expected to keep interest rates unchanged at 4.35% when it meets on Tuesday, June 18th, 2024, at 2:30 PM (AEST).

13:17, 17 June 2024

FOMC Decision Review: Rates unchanged as central bank raises inflation and interest rate forecasts

The FOMC left Federal Funds Rate unchanged at a target range of 5.25 to 5.50%.

10:55, 17 June 2024

Bank of Japan Preview: Markets look for guidance from BOJ about timing of next hike

The Bank of Japan meets on Friday, 14th of June, 2024. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

11:05, 12 June 2024

FOMC preview: Still expecting three rate cuts in 2024?

The Federal Reserve is expected to keep its policy unchanged on Wednesday – data from Reuters shows a 99% chance of no change. Last week’s 25-basis-point rate cut from the ECB has done nothing to change market expectations, and why should it?

08:20, 11 June 2024

US Non-Farm Payrolls Preview: Forecasts point to a stable labour market

US labour market conditions are expected to have remained stable in May. The latest Non-Farm Payrolls data will be released on Friday, June 7th, 2024, and will provide a health check on the US jobs market.

10:09, 5 June 2024

AUD/USD analysis: Focus turns to GDP data after unexpected CPI rise

Higher-than-expected monthly CPI data watered down expectations for RBA interest rate cuts in 2024; the markets will now shift attention to quarterly GDP data on Wednesday, June 5.

15:57, 4 June 2024

People also watch

XRP/USD

0.49 Price
-0.650% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

ETH/USD

3,510.78 Price
-0.480% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

US100

19,738.30 Price
-0.200% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

BTC/USD

64,320.45 Price
-1.260% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 620,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading